Gilead Sciences, Inc. (GILD) CEO Daniel O'Day on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 10/29/20
Gilead Sciences (GILD) Surpasses Q3 Earnings and Revenue EstimatesZacks Investment Research • 10/28/20
Gilead Sciences Posts Earnings Beat But Lowers Outlook, After GILD Stock Hits Seven-Year LowsInvestors Business Daily • 10/28/20
Fast start for coronavirus drug boosts Gilead earnings, sends stock higher in late tradingMarket Watch • 10/28/20
Gilead is set to sell billions of dollars of a coronavirus drug that's far from 'amazing' after the US approved remdesivir to treat COVID-19Business Insider • 10/24/20